The risk or severity of adverse effects can be increased when Artemether is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when codeine is combined with clorazepate.


The risk or severity of adverse effects can be increased when Pentolinium is combined with methscopolamine.


The risk or severity of adverse effects can be increased when pentazocine is combined with trazodone.


The risk or severity of adverse effects can be increased when budesonide is combined with decamethonium.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when trimipramine is combined with felbamate.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with cocaine.


The risk or severity of adverse effects can be increased when benazepril is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with triflupromazine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with zonisamide.


The risk or severity of adverse effects can be increased when ondansetron is combined with topiramate.


The risk or severity of adverse effects can be increased when nitrendipine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when amcinonide is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Desloratadine.


The risk or severity of adverse effects can be increased when diltiazem is combined with metolazone.


The risk or severity of adverse effects can be increased when benazepril is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when diltiazem is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when amiodarone is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Rifaximin is combined with clopidogrel.


The risk or severity of adverse effects can be increased when butabarbital is combined with thiamylal.


The risk or severity of adverse effects can be increased when promethazine is combined with doxepin.


The risk or severity of adverse effects can be increased when Tramadol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Tramadol is combined with bumetanide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with trazodone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Etomidate.


The risk or severity of adverse effects can be increased when sulpiride is combined with Normethadone.


The risk or severity of adverse effects can be increased when Butoconazole is combined with pravastatin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with bupivacaine.


The risk or severity of adverse effects can be increased when diclofenac is combined with sulindac.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with salicylamide.


The risk or severity of adverse effects can be increased when benzoic acid is combined with nifedipine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with risperidone.


The risk or severity of adverse effects can be increased when carbamazepine is combined with selegiline.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ATROPINE is combined with methscopolamine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with flutamide.


The risk or severity of adverse effects can be increased when loxapine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when loxapine is combined with glutethimide.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with tobramycin.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Asenapine.


The risk or severity of adverse effects can be increased when SULFADOXINE is combined with dapsone.


The risk or severity of adverse effects can be increased when Etidocaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with budesonide.


The risk or severity of adverse effects can be increased when butorphanol is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when zopiclone is combined with efavirenz.


The risk or severity of adverse effects can be increased when morphine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when morphine is combined with maprotiline.


The risk or severity of adverse effects can be increased when codeine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when codeine is combined with Etomidate.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Remoxipride.


The risk or severity of adverse effects can be increased when methadone is combined with procaine.


The risk or severity of adverse effects can be increased when methadone is combined with trimipramine.


The risk or severity of adverse effects can be increased when pergolide is combined with lomustine.


The risk or severity of adverse effects can be increased when pergolide is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when ondansetron is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with salicylamide.


The risk or severity of adverse effects can be increased when loxapine is combined with halothane.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Asenapine.


The risk or severity of adverse effects can be increased when quazepam is combined with Halazepam.


The risk or severity of adverse effects can be increased when Butethal is combined with felbamate.


The risk or severity of adverse effects can be increased when enflurane is combined with Pipamperone.


The risk or severity of adverse effects can be increased when nystatin is combined with nifedipine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with clozapine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when etizolam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when midazolam is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with promazine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with CABAZITAXEL.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with flunarizine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with enoxacin.


The risk or severity of adverse effects can be increased when codeine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with VERTEPORFIN.


The risk or severity of adverse effects can be increased when phenobarbital is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when thiopental is combined with fexofenadine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with nifedipine.


The risk or severity of adverse effects can be increased when methazolamide is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when methazolamide is combined with lisinopril.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with miconazole.


The risk or severity of adverse effects can be increased when clozapine is combined with thiopental.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when clozapine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when clozapine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfadimethoxine.


The risk or severity of adverse effects can be increased when clozapine is combined with doxazosin.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when nicergoline is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when scopolamine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when nicergoline is combined with paramethasone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with D-mannitol.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with nicardipine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with scopolamine.


The risk or severity of adverse effects can be increased when triazolam is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when butorphanol is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Tianeptine is combined with rasagiline.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with doxepin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Nebivolol.


The risk or severity of adverse effects can be increased when benzoic acid is combined with nimodipine.


The risk or severity of adverse effects can be increased when mesalamine is combined with Halobetasol.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Lopinavir.


The risk or severity of adverse effects can be increased when Masoprocol is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when levorphanol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when dyclonine is combined with tiapride.


The risk or severity of adverse effects can be increased when clozapine is combined with efavirenz.


The risk or severity of adverse effects can be increased when midazolam is combined with tiagabine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with betamethasone.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when selegiline is combined with bezafibrate.


The risk or severity of adverse effects can be increased when oxiconazole is combined with felodipine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with acetazolamide.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with diltiazem.


The risk or severity of adverse effects can be increased when Nepafenac is combined with estrone.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when butorphanol is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when oxiconazole is combined with manidipine.


The risk or severity of adverse effects can be increased when amcinonide is combined with mefloquine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with enflurane.


The risk or severity of adverse effects can be increased when Valganciclovir is combined with zidovudine.


The risk or severity of adverse effects can be increased when Nedaplatin is combined with topotecan.


The risk or severity of adverse effects can be increased when metoprolol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Rifampicin is combined with Lopinavir.


The risk or severity of adverse effects can be increased when buspirone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Bortezomib is combined with tolazoline.


The risk or severity of adverse effects can be increased when pimozide is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when nitrendipine is combined with spironolactone.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when atenolol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Propacetamol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with felbamate.


The risk or severity of adverse effects can be increased when amifostine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when pentazocine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with venlafaxine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with clemastine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with lidocaine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with doxepin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Regorafenib.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Aclidinium is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with duloxetine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Milnacipran.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when Spirapril is combined with antipyrine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with spironolactone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with methocarbamol.


The risk or severity of adverse effects can be increased when reserpine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when propoxyphene is combined with triprolidine.


The risk or severity of adverse effects can be increased when biperiden is combined with topiramate.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Difenoxin.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with felbamate.


The risk or severity of adverse effects can be increased when zopiclone is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when buprenorphine is combined with furosemide.


The risk or severity of adverse effects can be increased when benztropine is combined with Tramadol.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with salicylic acid.


The risk or severity of adverse effects can be increased when nicergoline is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Perospirone.


The risk or severity of adverse effects can be increased when cinnarizine is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when nicergoline is combined with Caspofungin.


The risk or severity of adverse effects can be increased when perphenazine is combined with zonisamide.


The risk or severity of adverse effects can be increased when thiothixene is combined with Lurasidone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with rasagiline.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Retigabine.


The risk or severity of adverse effects can be increased when perphenazine is combined with ondansetron.


The risk or severity of adverse effects can be increased when Avanafil is combined with alprostadil.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with carisoprodol.


The risk or severity of adverse effects can be increased when reserpine is combined with phenobarbital.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Vinflunine is combined with mitomycin C.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with pilocarpine.


The risk or severity of adverse effects can be increased when olanzapine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when minoxidil is combined with enalapril.


The risk or severity of adverse effects can be increased when barnidipine is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when barnidipine is combined with fluvastatin.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when amobarbital is combined with butalbital.


The risk or severity of adverse effects can be increased when Lofexidine is combined with pramipexole.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with galanthamine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with propoxyphene.


The risk or severity of adverse effects can be increased when pentazocine is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with dyclonine.


The risk or severity of adverse effects can be increased when quinapril is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when enflurane is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with tretinoin.


The risk or severity of adverse effects can be increased when Rotigotine is combined with losartan.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with isoflurane.


The risk or severity of adverse effects can be increased when nitric oxide is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when enflurane is combined with lidocaine.


The risk or severity of adverse effects can be increased when lisinopril is combined with alclofenac.


The risk or severity of adverse effects can be increased when enflurane is combined with clemastine.


The risk or severity of adverse effects can be increased when enflurane is combined with venlafaxine.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Amrinone.


The risk or severity of adverse effects can be increased when suprofen is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when thiothixene is combined with glutethimide.


The risk or severity of adverse effects can be increased when amifostine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when thiothixene is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when cabergoline is combined with DALFOPRISTIN.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Quinine is combined with mefloquine.


The risk or severity of adverse effects can be increased when butamben is combined with loratadine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Pramocaine.


The risk or severity of adverse effects can be increased when tolmetin is combined with Icatibant.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with bezafibrate.


The risk or severity of adverse effects can be increased when prilocaine is combined with promethazine.


The risk or severity of adverse effects can be increased when Salbutamol is combined with atorvastatin.


The risk or severity of adverse effects can be increased when butamben is combined with imipramine.


The risk or severity of adverse effects can be increased when clidinium is combined with zonisamide.


The risk or severity of adverse effects can be increased when Melatonin is combined with brotizolam.


The risk or severity of adverse effects can be increased when bumetanide is combined with methyldopa.


The risk or severity of adverse effects can be increased when bumetanide is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Tasimelteon is combined with Escitalopram.


The risk or severity of adverse effects can be increased when bumetanide is combined with apraclonidine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Cabozantinib.


The risk or severity of adverse effects can be increased when enflurane is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when enflurane is combined with prilocaine.


The risk or severity of adverse effects can be increased when enflurane is combined with ethotoin.


The risk or severity of adverse effects can be increased when mesoridazine is combined with flunarizine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when IODIPAMIDE is combined with metformin.


The risk or severity of adverse effects can be increased when morphine is combined with Torasemide.


The risk or severity of adverse effects can be increased when reserpine is combined with quinapril.


The risk or severity of adverse effects can be increased when hexetidine is combined with xylometazoline.


The risk or severity of adverse effects can be increased when oxaprozin is combined with fluocinonide.


The risk or severity of adverse effects can be increased when clomipramine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when paroxetine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when gabapentin is combined with lithium ion.


The risk or severity of adverse effects can be increased when nystatin is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when gabapentin is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when meprobamate is combined with Ramelteon.


The risk or severity of adverse effects can be increased when gabapentin is combined with Butethal.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when nisoldipine is combined with methazolamide.


The risk or severity of adverse effects can be increased when zotepine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when ketamine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when ibuprofen is combined with nimesulide.


The risk or severity of adverse effects can be increased when nicergoline is combined with Elbasvir.


The risk or severity of adverse effects can be increased when dipyridamole is combined with Olsalazine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Difenoxin.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with fenbufen.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when polythiazide is combined with carbamazepine.


The risk or severity of adverse effects can be increased when imipramine is combined with sumatriptan.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Fospropofol.


The risk or severity of adverse effects can be increased when lisinopril is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when suprofen is combined with dexamethasone.


The risk or severity of adverse effects can be increased when isoflurane is combined with nitrendipine.


The risk or severity of adverse effects can be increased when carboplatin is combined with topotecan.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Riociguat.


The risk or severity of adverse effects can be increased when Clofarabine is combined with halothane.


The risk or severity of adverse effects can be increased when aspirin is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when thiothixene is combined with scopolamine.


The risk or severity of adverse effects can be increased when terconazole is combined with bepridil.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when clozapine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Asenapine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when protriptyline is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Eletriptan is combined with desipramine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when tolmetin is combined with Naftifine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with ibuprofen.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Perospirone.


The risk or severity of adverse effects can be increased when haloperidol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when amphotericin b is combined with nitrendipine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with tetracaine.


The risk or severity of adverse effects can be increased when imipramine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when imipramine is combined with tolazoline.


The risk or severity of adverse effects can be increased when flumethasone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when prazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when furazolidone is combined with clenbuterol.


The risk or severity of adverse effects can be increased when Tiotropium is combined with buprenorphine.


The risk or severity of adverse effects can be increased when cocaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when zotepine is combined with Retigabine.


The risk or severity of adverse effects can be increased when cocaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when thiamylal is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with bromazepam.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with glutethimide.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when Carbetocin is combined with bumetanide.


The risk or severity of adverse effects can be increased when Carbetocin is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Carbetocin is combined with quinapril.


The risk or severity of adverse effects can be increased when Carbetocin is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when furosemide is combined with Eplerenone.


The risk or severity of adverse effects can be increased when pimozide is combined with dibucaine.


The risk or severity of adverse effects can be increased when SAQUINAVIR is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Normethadone.


The risk or severity of adverse effects can be increased when Halazepam is combined with lithium ion.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when butorphanol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Apremilast.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Pemetrexed.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when thalidomide is combined with trandolapril.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with ranitidine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with clemastine.


The risk or severity of adverse effects can be increased when zonisamide is combined with clonazepam.


The risk or severity of adverse effects can be increased when nortriptyline is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when tetracaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Etomidate.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when metoprolol is combined with papaverine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when enalapril is combined with acebutolol.


The risk or severity of adverse effects can be increased when amifostine is combined with propofol.


The risk or severity of adverse effects can be increased when salicylic acid is combined with cilnidipine.


The risk or severity of adverse effects can be increased when atenolol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when cilnidipine is combined with tolazoline.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when cilnidipine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when ethotoin is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when rasagiline is combined with Isometheptene.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with ibuprofen.


The risk or severity of adverse effects can be increased when loratadine is combined with tiagabine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when nortriptyline is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when lorazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when lorazepam is combined with risperidone.


The risk or severity of adverse effects can be increased when zonisamide is combined with dantrolene.


The risk or severity of adverse effects can be increased when rasagiline is combined with droxidopa.


The risk or severity of adverse effects can be increased when methylergonovine is combined with zafirlukast.


The risk or severity of adverse effects can be increased when Pramocaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Halazepam is combined with Butethal.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Nepafenac.


The risk or severity of adverse effects can be increased when salicylic acid is combined with manidipine.


The risk or severity of adverse effects can be increased when butorphanol is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with HEROIN.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Articaine.


The risk or severity of adverse effects can be increased when mefloquine is combined with Varenicline.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when fluoxetine is combined with desipramine.


The risk or severity of adverse effects can be increased when atenolol is combined with trandolapril.


The risk or severity of adverse effects can be increased when Vilazodone is combined with zolmitriptan.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with nicardipine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with tizanidine.


The risk or severity of adverse effects can be increased when imipramine is combined with papaverine.


The risk or severity of adverse effects can be increased when imipramine is combined with nifedipine.


The risk or severity of adverse effects can be increased when phenylephrine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Asenapine is combined with etizolam.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with methazolamide.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when amobarbital is combined with MELPERONE.


The risk or severity of adverse effects can be increased when flumethasone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Perospirone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when ramipril is combined with nimesulide.


The risk or severity of adverse effects can be increased when Propacetamol is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with diflorasone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with nilvadipine.


The risk or severity of adverse effects can be increased when bromazepam is combined with Butethal.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when bromazepam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when bromazepam is combined with lithium ion.


The risk or severity of adverse effects can be increased when amisulpride is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when cabergoline is combined with ROLITETRACYCLINE.


The risk or severity of adverse effects can be increased when Telmisartan is combined with carvedilol.


The risk or severity of adverse effects can be increased when Trospium is combined with codeine.


The risk or severity of adverse effects can be increased when methenamine is combined with sulfisoxazole.


The risk or severity of adverse effects can be increased when bumetanide is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when lorazepam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when nortriptyline is combined with vigabatrin.


The risk or severity of adverse effects can be increased when lorazepam is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with lithium ion.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Butethal.


The risk or severity of adverse effects can be increased when sevoflurane is combined with amobarbital.


The risk or severity of adverse effects can be increased when bepridil is combined with acebutolol.


The risk or severity of adverse effects can be increased when Tianeptine is combined with Salmeterol.


The risk or severity of adverse effects can be increased when meprobamate is combined with flunarizine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when sevoflurane is combined with penbutolol.


The risk or severity of adverse effects can be increased when butabarbital is combined with meperidine.


The risk or severity of adverse effects can be increased when procyclidine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when 5-azacytidine is combined with leflunomide.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with penbutolol.


The risk or severity of adverse effects can be increased when levodopa is combined with Retigabine.


The risk or severity of adverse effects can be increased when loxapine is combined with Asenapine.


The risk or severity of adverse effects can be increased when secobarbital is combined with thioridazine.


The risk or severity of adverse effects can be increased when floctafenine is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Masoprocol is combined with triamcinolone.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Pramocaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Naftifine is combined with loteprednol.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when butalbital is combined with triprolidine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with methadone.


The risk or severity of adverse effects can be increased when methysergide is combined with acetaminophen.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with bumetanide.


The risk or severity of adverse effects can be increased when Metixene is combined with methscopolamine.


The risk or severity of adverse effects can be increased when clonidine is combined with hydralazine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with quinapril.


The risk or severity of adverse effects can be increased when Conivaptan is combined with bumetanide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with topiramate.


The risk or severity of adverse effects can be increased when oxymorphone is combined with triamterene.


The risk or severity of adverse effects can be increased when prilocaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with tretinoin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with ethotoin.


The risk or severity of adverse effects can be increased when diclofenac is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when sevoflurane is combined with prilocaine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when oxazepam is combined with bromazepam.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Micafungin is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with prazosin.


The risk or severity of adverse effects can be increased when Pipamperone is combined with fosinopril.


The risk or severity of adverse effects can be increased when lisinopril is combined with captopril.


The risk or severity of adverse effects can be increased when Droxicam is combined with estrone.


The risk or severity of adverse effects can be increased when azelastine is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when azelastine is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Escitalopram.


The risk or severity of adverse effects can be increased when prednisone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when naratriptan is combined with clozapine.


The risk or severity of adverse effects can be increased when clorazepate is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with clidinium.


The risk or severity of adverse effects can be increased when perphenazine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with lidocaine.


The risk or severity of adverse effects can be increased when chloramphenicol is combined with atorvastatin.


The risk or severity of adverse effects can be increased when penbutolol is combined with Nebivolol.


The risk or severity of adverse effects can be increased when metoprolol is combined with nimodipine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with nefazodone.


The risk or severity of adverse effects can be increased when carbamazepine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when doxylamine is combined with citalopram.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Lacidipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with cilazapril.


The risk or severity of adverse effects can be increased when betaxolol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when betaxolol is combined with Metipranolol.


The risk or severity of adverse effects can be increased when spironolactone is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when Pipamperone is combined with lisinopril.


The risk or severity of adverse effects can be increased when oxazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with irbesartan.


The risk or severity of adverse effects can be increased when Pipamperone is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Pipamperone is combined with trimipramine.


The risk or severity of adverse effects can be increased when isoflurane is combined with ethotoin.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Retigabine.


The risk or severity of adverse effects can be increased when isoflurane is combined with prilocaine.


The risk or severity of adverse effects can be increased when HEROIN is combined with zonisamide.


The risk or severity of adverse effects can be increased when isoflurane is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with papaverine.


The risk or severity of adverse effects can be increased when halothane is combined with chlormezanone.


The risk or severity of adverse effects can be increased when HEROIN is combined with tiagabine.


The risk or severity of adverse effects can be increased when oxazepam is combined with zotepine.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with diazoxide.


The risk or severity of adverse effects can be increased when Lurasidone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when HEROIN is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when loxapine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when loxapine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when aspirin is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when aspirin is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when levorphanol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when enflurane is combined with mepivacaine.


The risk or severity of adverse effects can be increased when valsartan is combined with Nepafenac.


The risk or severity of adverse effects can be increased when amiodarone is combined with fenoldopam.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with selegiline.


The risk or severity of adverse effects can be increased when Eletriptan is combined with buspirone.


The risk or severity of adverse effects can be increased when apomorphine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when ethosuximide is combined with paroxetine.


The risk or severity of adverse effects can be increased when apomorphine is combined with Conivaptan.


The risk or severity of adverse effects can be increased when isoflurane is combined with clemastine.


The risk or severity of adverse effects can be increased when isoflurane is combined with lidocaine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with ethotoin.


The risk or severity of adverse effects can be increased when sulindac is combined with azelastine.


The risk or severity of adverse effects can be increased when triprolidine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with prilocaine.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with DESONIDE.


The risk or severity of adverse effects can be increased when trandolapril is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when morphine is combined with Drospirenone.


The risk or severity of adverse effects can be increased when glutethimide is combined with cetirizine.


The risk or severity of adverse effects can be increased when ketamine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when glutethimide is combined with protriptyline.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with tretinoin.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when halothane is combined with zonisamide.


The risk or severity of adverse effects can be increased when tretinoin is combined with Aliskiren.


The risk or severity of adverse effects can be increased when olanzapine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when lidocaine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with zonisamide.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Tramadol is combined with diazepam.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with cocaine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with tiagabine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Retigabine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with baclofen.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Droxicam.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Milnacipran.


The risk or severity of adverse effects can be increased when clomipramine is combined with nifedipine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with tolmetin.


The risk or severity of adverse effects can be increased when clomipramine is combined with papaverine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Normethadone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with tubocurarine.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with dobutamine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with nitrendipine.


The risk or severity of adverse effects can be increased when ketorolac is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Normethadone is combined with doxepin.


The risk or severity of adverse effects can be increased when triazolam is combined with quetiapine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when triazolam is combined with ketamine.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Halobetasol.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when pentobarbital is combined with glutethimide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Etomidate is combined with prilocaine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Etomidate is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when procaine is combined with citalopram.


The risk or severity of adverse effects can be increased when Etomidate is combined with ethotoin.


The risk or severity of adverse effects can be increased when phenylephrine is combined with terbutaline.


The risk or severity of adverse effects can be increased when nimesulide is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when sulfamethazine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when estazolam is combined with duloxetine.


The risk or severity of adverse effects can be increased when ketamine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when estazolam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when allopurinol is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with scopolamine.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with donepezil.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with proparacaine.


The risk or severity of adverse effects can be increased when isoflurane is combined with halothane.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Halazepam.


The risk or severity of adverse effects can be increased when Salsalate is combined with betamethasone.


The risk or severity of adverse effects can be increased when propofol is combined with propranolol.


The risk or severity of adverse effects can be increased when risperidone is combined with dantrolene.


The risk or severity of adverse effects can be increased when isoflurane is combined with desipramine.


The risk or severity of adverse effects can be increased when propofol is combined with clonidine.


The risk or severity of adverse effects can be increased when Nabilone is combined with indapamide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Pramocaine.


The risk or severity of adverse effects can be increased when metolazone is combined with digitoxin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with thiamylal.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Butethal is combined with Perospirone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with halothane.


The risk or severity of adverse effects can be increased when Clofarabine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when metaraminol is combined with Ephedrine.


The risk or severity of adverse effects can be increased when bepridil is combined with imipramine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with nicotinamide.


The risk or severity of adverse effects can be increased when apomorphine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when quazepam is combined with tetracaine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with suprofen.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with loteprednol.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with propoxyphene.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with polythiazide.


The risk or severity of adverse effects can be increased when bepridil is combined with prazosin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with promethazine.


The risk or severity of adverse effects can be increased when indomethacin is combined with diflunisal.


The risk or severity of adverse effects can be increased when HEROIN is combined with PAMABROM.


The risk or severity of adverse effects can be increased when diclofenac is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when prilocaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when formestane is combined with Echothiophate.


The risk or severity of adverse effects can be increased when bromazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Eplerenone.


The risk or severity of adverse effects can be increased when metolazone is combined with irbesartan.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when Vecuronium is combined with morphine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with thiamylal.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with enoxacin.


The risk or severity of adverse effects can be increased when Perospirone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with tolmetin.


The risk or severity of adverse effects can be increased when formestane is combined with norfloxacin.


The risk or severity of adverse effects can be increased when flurazepam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Prasugrel is combined with Olsalazine.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with cilnidipine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when halcinonide is combined with Deferasirox.


The risk or severity of adverse effects can be increased when antipyrine is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when antipyrine is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Butethal.


The risk or severity of adverse effects can be increased when manidipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Fospropofol.


The risk or severity of adverse effects can be increased when carvedilol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when topiramate is combined with METAXALONE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with ambenonium.


The risk or severity of adverse effects can be increased when ipratropium is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Halazepam.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with D-mannitol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with proparacaine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with scopolamine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with rasagiline.


The risk or severity of adverse effects can be increased when labetalol is combined with hydralazine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with nifedipine.


The risk or severity of adverse effects can be increased when propofol is combined with sulpiride.


The risk or severity of adverse effects can be increased when labetalol is combined with Varenicline.


The risk or severity of adverse effects can be increased when propofol is combined with nimodipine.


The risk or severity of adverse effects can be increased when triamcinolone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when etodolac is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Propiverine.


The risk or severity of adverse effects can be increased when etodolac is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when furosemide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when oxprenolol is combined with felbamate.


The risk or severity of adverse effects can be increased when ropinirole is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when propofol is combined with thiothixene.


The risk or severity of adverse effects can be increased when propofol is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Salsalate is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when indapamide is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Masoprocol is combined with salicylamide.


The risk or severity of adverse effects can be increased when MELPERONE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with clonidine.


The risk or severity of adverse effects can be increased when barnidipine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with cilazapril.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when barnidipine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Normethadone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with perphenazine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when nilvadipine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Torasemide.


The risk or severity of adverse effects can be increased when mecamylamine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when selegiline is combined with tiapride.


The risk or severity of adverse effects can be increased when Torasemide is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Perospirone.


The risk or severity of adverse effects can be increased when butabarbital is combined with Flupentixol.


The risk or severity of adverse effects can be increased when dibucaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when metoclopramide is combined with acetylcholine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with budesonide.


The risk or severity of adverse effects can be increased when perphenazine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with nitrofurantoin.


The risk or severity of adverse effects can be increased when Efonidipine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when meperidine is combined with Melatonin.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when naratriptan is combined with perphenazine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Perospirone.


The risk or severity of adverse effects can be increased when cabergoline is combined with hydralazine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with prilocaine.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when celiprolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when brotizolam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when pimozide is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when topiramate is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with tiapride.


The risk or severity of adverse effects can be increased when pimozide is combined with quazepam.


The risk or severity of adverse effects can be increased when pimozide is combined with prazepam.


The risk or severity of adverse effects can be increased when meperidine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when sotalol is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when morniflumate is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when sotalol is combined with lisinopril.


The risk or severity of adverse effects can be increased when zopiclone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Pomalidomide is combined with paroxetine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with selegiline.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with oxycodone.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when atenolol is combined with cilazapril.


The risk or severity of adverse effects can be increased when protriptyline is combined with Flibanserin.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when chloroquine is combined with leflunomide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when carisoprodol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when methylene blue is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when Tramadol is combined with loratadine.


The risk or severity of adverse effects can be increased when Tramadol is combined with meperidine.


The risk or severity of adverse effects can be increased when Aclidinium is combined with Tramadol.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with ketoprofen.


The risk or severity of adverse effects can be increased when cabergoline is combined with promethazine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when sumatriptan is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when codeine is combined with doxepin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when dacarbazine is combined with clozapine.


The risk or severity of adverse effects can be increased when celecoxib is combined with tolmetin.


The risk or severity of adverse effects can be increased when celecoxib is combined with haloperidol.


The risk or severity of adverse effects can be increased when quinidine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Eplerenone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Naftifine.


The risk or severity of adverse effects can be increased when oxazepam is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Amrinone.


The risk or severity of adverse effects can be increased when PROCATEROL is combined with clenbuterol.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Efonidipine is combined with spironolactone.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when Ditazole is combined with Treprostinil.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when diclofenac is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when carbamazepine is combined with enflurane.


The risk or severity of adverse effects can be increased when oxybutynin is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with methocarbamol.


The risk or severity of adverse effects can be increased when pentobarbital is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when amobarbital is combined with trazodone.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with triprolidine.


The risk or severity of adverse effects can be increased when trimipramine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when zopiclone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Rufinamide is combined with etizolam.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Fospropofol.


The risk or severity of adverse effects can be increased when clidinium is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when orphenadrine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when clidinium is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when clozapine is combined with cilazapril.


The risk or severity of adverse effects can be increased when baclofen is combined with efavirenz.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with glutethimide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when valsartan is combined with trandolapril.


The risk or severity of adverse effects can be increased when quazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when quazepam is combined with amoxapine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with ropinirole.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when captopril is combined with suprofen.


The risk or severity of adverse effects can be increased when aspirin is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfisoxazole.


The risk or severity of adverse effects can be increased when loteprednol is combined with physostigmine.


The risk or severity of adverse effects can be increased when Limaprost is combined with warfarin.


The risk or severity of adverse effects can be increased when scopolamine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Limaprost is combined with pentosan polysulfate.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Halazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when Tramadol is combined with polythiazide.


The risk or severity of adverse effects can be increased when Tramadol is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when benazepril is combined with methazolamide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with lisinopril.


The risk or severity of adverse effects can be increased when meperidine is combined with amisulpride.


The risk or severity of adverse effects can be increased when tenoxicam is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when indomethacin is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Eprosartan is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with doxazosin.


The risk or severity of adverse effects can be increased when Eprosartan is combined with oxaprozin.


The risk or severity of adverse effects can be increased when leflunomide is combined with Clobetasone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with labetalol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with thiopental.


The risk or severity of adverse effects can be increased when chlormezanone is combined with dantrolene.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when dantrolene is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when pimozide is combined with procaine.


The risk or severity of adverse effects can be increased when etodolac is combined with epirizole.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with rescinnamine.


The risk or severity of adverse effects can be increased when methadone is combined with propoxyphene.


The risk or severity of adverse effects can be increased when oxycodone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when methazolamide is combined with penbutolol.


The risk or severity of adverse effects can be increased when sulpiride is combined with METAXALONE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Trilostane.


The risk or severity of adverse effects can be increased when phenobarbital is combined with ethotoin.


The risk or severity of adverse effects can be increased when phenobarbital is combined with prilocaine.


The risk or severity of adverse effects can be increased when promazine is combined with levorphanol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with CAPECITABINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with primidone.


The risk or severity of adverse effects can be increased when thioridazine is combined with tolazoline.


The risk or severity of adverse effects can be increased when thioridazine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with paroxetine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Sacubitril is combined with carvedilol.


The risk or severity of adverse effects can be increased when meprobamate is combined with fludiazepam.


The risk or severity of adverse effects can be increased when meprobamate is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when 3,4-Dihydroxybenzaldehyde is combined with Deferasirox.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Icatibant.


The risk or severity of adverse effects can be increased when Telmisartan is combined with tenoxicam.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when midazolam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Telmisartan is combined with nabumetone.


The risk or severity of adverse effects can be increased when enalapril is combined with penbutolol.


The risk or severity of adverse effects can be increased when Telmisartan is combined with ketorolac.


The risk or severity of adverse effects can be increased when proparacaine is combined with lithium ion.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when proparacaine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Tiotropium is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when atenolol is combined with irbesartan.


The risk or severity of adverse effects can be increased when doxazosin is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when doxazosin is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with thiotepa.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with fleroxacin.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when atenolol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when amitriptyline is combined with triprolidine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when amitriptyline is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Fludarabine is combined with pentostatin.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Flibanserin.


The risk or severity of adverse effects can be increased when proparacaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when quazepam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when butorphanol is combined with quetiapine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with tretinoin.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when thiothixene is combined with felbamate.


The risk or severity of adverse effects can be increased when furosemide is combined with Bretylium.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with benzocaine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when dexamethasone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when rapamycin is combined with barnidipine.


The risk or severity of adverse effects can be increased when bumetanide is combined with Valrubicin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with dibucaine.


The risk or severity of adverse effects can be increased when atenolol is combined with enalapril.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when amphotericin b is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when selegiline is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when mequitazine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when isoflurane is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when flumethasone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when pimozide is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Perospirone.


The risk or severity of adverse effects can be increased when Olsalazine is combined with acemetacin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with zotepine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with MELPERONE.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when alprenolol is combined with nicotine.


The risk or severity of adverse effects can be increased when alprenolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when Vecuronium is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when chloroquine is combined with Tixocortol.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with ribostamycin.


The risk or severity of adverse effects can be increased when Propiverine is combined with butorphanol.


The risk or severity of adverse effects can be increased when promazine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when duloxetine is combined with periciazine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with scopolamine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with rizatriptan.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with naratriptan.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Pizotifen.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when carprofen is combined with oxaprozin.


The risk or severity of adverse effects can be increased when alprazolam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with nisoldipine.


The risk or severity of adverse effects can be increased when dibucaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Lurasidone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with loratadine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with prazosin.


The risk or severity of adverse effects can be increased when resveratrol is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when resveratrol is combined with amcinonide.


The risk or severity of adverse effects can be increased when midodrine is combined with epinephrine.


The risk or severity of adverse effects can be increased when enalapril is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when budesonide is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with benzocaine.


The risk or severity of adverse effects can be increased when budesonide is combined with memantine.


The risk or severity of adverse effects can be increased when clomipramine is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when morphine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Pipamperone is combined with clonazepam.


The risk or severity of adverse effects can be increased when diazepam is combined with thiopental.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with equilin.


The risk or severity of adverse effects can be increased when ILOPROST is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when diazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Pregabalin is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when dapsone is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with prednisone.


The risk or severity of adverse effects can be increased when reserpine is combined with phenytoin.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Agomelatine.


The risk or severity of adverse effects can be increased when morphine is combined with flunarizine.


The risk or severity of adverse effects can be increased when irbesartan is combined with carprofen.


The risk or severity of adverse effects can be increased when triflupromazine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when methysergide is combined with Topiroxostat.


The risk or severity of adverse effects can be increased when pentobarbital is combined with olanzapine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with xylometazoline.


The risk or severity of adverse effects can be increased when triamcinolone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when nicergoline is combined with antipyrine.


The risk or severity of adverse effects can be increased when trimethoprim is combined with dapsone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with terazosin.


The risk or severity of adverse effects can be increased when paramethasone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when quinapril is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Pirlindole is combined with hydromorphone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with halothane.


The risk or severity of adverse effects can be increased when buspirone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with clemastine.


The risk or severity of adverse effects can be increased when argatroban is combined with diflunisal.


The risk or severity of adverse effects can be increased when paramethasone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when Aclidinium is combined with HEROIN.


The risk or severity of adverse effects can be increased when suprofen is combined with amcinonide.